The use of GLP-1 receptor agonists and subsequent risk of nicotine-related events: a cross- sectional study.

BMC Public Health · 2026 · PMC12998102 · PMID 41673636

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

These results demonstrate a clear trend toward reduced nicotine cravings among participants following the use of GLP-1 (Table S1, Fig. 3 ).

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.